“The allegations in the complaint highlight serious violations of securities laws. If proven true, Humacyte's alleged failure to disclose material information to investors is unacceptable,” said Reed ...
On Friday, Humacyte Inc (HUMA) stock saw a modest uptick, ending the day at $4.47 which represents a slight increase of $0.07 or 1.59% from the prior close of $4.4. The stock opened at $4.44 and ...
Humacyte Inc’s profitability metrics reveal financial health. The company currently boasts an operating margin of 0.00% with a gross margin of -41.67%. The profit margin, also known as the revenue ...
Humacyte, Inc.(纳斯达克股票代码:HUMA)的总裁、首席执行官兼董事Laura E. Niklason最近购买了1,797股公司普通股。这些股票的平均购买价格为每股4.44美元,总交易价值为7,978美元。此次交易后,Niklason直接持有243,851股。此外,她还通过The Niklason Living Trust和Ayabudge LLC等多个实体间接持有股份。